Charles Schwab Investment Management Inc Harrow Health, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 255,218 shares of HROW stock, worth $6.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
255,218
Previous 251,629
1.43%
Holding current value
$6.7 Million
Previous $11.3 Million
24.32%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$105 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$56.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$49.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$44.5 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$23.8 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $711M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...